Jack Higgins - 27 Mar 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Reporting relationship: Chief Scientific Officer
Issuer ticker: IMNM
Reported as of: 27 Mar 2025
Net transaction value: +$7,020
SEC form: 4
Accepted by SEC: 28 Mar 2025, 17:54:02 UTC
Prior SEC filing: 19 Aug 2024
Next SEC filing: 31 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Sandra Stoneman, Attorney-in-Fact

Key filing fact

Jack Higgins filed Form 4 for Immunome Inc. (IMNM) on 28 Mar 2025.

Key facts

This page summarizes Jack Higgins's Form 4 filing for Immunome Inc. (IMNM).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Mar 2025, 17:54.

Change

Previous filing in this sequence was filed on 19 Aug 2024.
Current net transaction value: +$7,020.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMNM transaction

Common Stock

Options Exercise

Transaction value: $7,020
Shares: +5,200
Change %: +38%
Price: $1.35
Shares after: 18,729
Date: 27 Mar 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMNM transaction Derivative

Employee Stock option (right to buy)

Options Exercise

Transaction value: $0
Shares: -5,200
Change %: -2.9%
Price: $0.000000
Shares after: 173,840
Date: 27 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,200
Exercise price: $1.35
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .